default author photo

Stefano De Santis

Johnson & Johnson

New Brunswick, NJ 08933

United States

  • Johnson & Johnson

SCHOLARLY PAPERS

1

DOWNLOADS

56

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Evaluation of Non-Invasive Low-Risk Criteria in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A 12-Months Analysis from the Inspectio Study

Number of pages: 23 Posted: 01 Jul 2025
Livio Giuliani, Michele D'Alto, Emma Di Poi, Lorenzo Dagna, Federico Guerra, Marco Corda, Gian Piero Perna, Andrea Doria, Roberto Badagliacca, Marco Vicenzi, Edoardo Airò, Matteo Toma, Laura Scelsi, Cristina Piccinino, Natale Daniele Brunetti, Carlo Mario Lombardi, Fabiana Baldi, Matteo Biancospino, Alessia Uglietti and Stefano De Santis
San Salvatore Hospital, AORN dei Colli - Monaldi Hospital, affiliation not provided to SSRN, Università Vita-Salute San Raffaele - San Raffaele Hospital, University Hospital “Ospedali Riuniti” - Cardiology And Arrhythmology Clinic, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Padua, "Sapienza" University of Rome - Department of Cardiovascular and Respiratory Diseases, University of Milan, affiliation not provided to SSRN, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Ospedale Policlinico San Martino, Fondazione IRCCS Policlinico San matteo, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Brescia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Johnson & Johnson, Johnson & Johnson and Johnson & Johnson
Downloads 56 (1,010,164)

Abstract:

Loading...

Pulmonary arterial hypertension, Connective tissue disease, Macitentan, Selexipag, Risk stratification, Real-world evidence.